BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30025200)

  • 1. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
    Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
    Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
    Joo EJ; Chang Y; Yeom JS; Ryu S
    Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
    Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
    Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.
    Cho HJ; Hwang S; Park JI; Yang MJ; Hwang JC; Yoo BM; Lee KM; Shin SJ; Lee KJ; Kim JH; Cheong JY; Cho SW; Kim SS
    Gut Liver; 2019 Apr; 13(4):440-449. PubMed ID: 30970431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
    Yu MW; Lin CL; Liu CJ; Huang YW; Hu JT; Wu WJ; Wu CF
    J Formos Med Assoc; 2022 Aug; 121(8):1478-1487. PubMed ID: 34764005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
    Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
    Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.